India  

Bharat Biotech's indigenous COVID-19 vaccine 'COVAXIN' gets approval for phase I & II human clinical trials

DNA Tuesday, 30 June 2020
The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech. The indigenous inactivated vaccine was developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) High Containment facility located in Genome Valley, Hyderabad.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Novavax Jumps 13% After UK Deal For 60 Million Doses Of COVID Vaccine [Video]

Novavax Jumps 13% After UK Deal For 60 Million Doses Of COVID Vaccine

On Friday, shares of Novavax leaped as much as 13.3%. It comes after Novavax finalized a deal with the UK to supply 60 million doses of its potential coronavirus vaccine. The biotech company didn't..

Credit: Wochit     Duration: 00:23Published
Laboratory in Argentina assured the vaccine against COVID-19 will be ready by December [Video]

Laboratory in Argentina assured the vaccine against COVID-19 will be ready by December

The owner of Grupo Insud, Hugo Sigman, confirmed through Radio Mitre that the vaccine developed by the University of Oxford in Argentina has already begun its production and will be ready by December..

Credit: Newsflare     Duration: 02:25Published
Officials Concerned With Russia’s COVID Vaccine [Video]

Officials Concerned With Russia’s COVID Vaccine

Officials Concerned With Russia’s COVID Vaccine

Credit: Wochit Business     Duration: 00:26Published

Related news from verified sources

DCGI gives nod to Bharat Biotech to conduct phase I and II Human clinical trials to develop vaccine

New Delhi: The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited (BBIL) to conduct Phase I and II Human...
Mid-Day

India’s first Covid-19 vaccine candidate by Hyderabad-based Bharat Biotech set for trials

India’s first Covid-19 vaccine candidate Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the National Institute of Virology (NIV),...
IndiaTimes


Tweets about this